JenaValve Presents ALIGN-AR 2-Year Follow-Up Data at TCT 2024 and Announces Commencement of ARTIST Randomized Controlled Trial (RCT)
IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve...